106 related articles for article (PubMed ID: 36105077)
1. The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action.
Pandini C; Pagani G; Tassinari M; Vitale E; Bezzecchi E; Saadeldin MK; Doldi V; Giannuzzi G; Mantovani R; Chiara M; Ciarrocchi A; Gandellini P
Cell Death Dis; 2024 Mar; 15(3):206. PubMed ID: 38467619
[TBL] [Abstract][Full Text] [Related]
2. Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma.
Tong F; Xu L; Xu S; Zhang M
Front Genet; 2022; 13():834935. PubMed ID: 36105077
[No Abstract] [Full Text] [Related]
3. Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma.
Tong F; Xu L; Xu S; Zhang M
Front Genet; 2022; 13():1050296. PubMed ID: 36386796
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma.
Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Liang X; Yao Y
J Thorac Dis; 2021 Feb; 13(2):720-734. PubMed ID: 33717544
[TBL] [Abstract][Full Text] [Related]
5. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
Front Genet; 2022; 13():966896. PubMed ID: 36186456
[No Abstract] [Full Text] [Related]
7. LncRNA CASC2 inhibits autophagy and promotes apoptosis in non-small cell lung cancer cells
Li Q; Chen K; Dong R; Lu H
RSC Adv; 2018 Dec; 8(71):40846-40855. PubMed ID: 35557905
[No Abstract] [Full Text] [Related]
8. LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins.
Song Y; Du J; Lu P; Zou Q; Zeng S; Liu M; Hu X; Ma W; Lin H; Liu X; Niu F
Ann Transl Med; 2021 Nov; 9(21):1621. PubMed ID: 34926665
[TBL] [Abstract][Full Text] [Related]
9. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway.
Shang B; Li Z; Li M; Jiang S; Feng Z; Cao Z; Wang H
Thorac Cancer; 2021 Jul; 12(14):2093-2103. PubMed ID: 34061456
[TBL] [Abstract][Full Text] [Related]
10. A novel autophagy-related lncRNA survival model for lung adenocarcinoma.
Wu L; Wen Z; Song Y; Wang L
J Cell Mol Med; 2021 Jun; 25(12):5681-5690. PubMed ID: 33987935
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis.
Zhu Y; Zhao J; Tan L; Lin S; Long M; Peng X
Pathol Res Pract; 2021 May; 221():153395. PubMed ID: 33798913
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
